Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Neoplasms 3Prostatic Neoplasms 2Pain, Postoperative 2Pain 2Neuroma 2Chronic Pain 2Breast Diseases 2Wounds and Injuries 1Stroke 1Stomach Neoplasms 1Spinal Cord Injuries 1Skin Diseases 1Rectal Neoplasms 1Prostatic Hyperplasia 1Pancreatic Neoplasms 1Neoplasms by Site 1Muscular Atrophy 1Muscle Spasticity 1Lower Urinary Tract Symptoms 1Low Anterior Resection Syndrome 1Hereditary leiomyomatosis and renal cell cancer 1Head and Neck Neoplasms 1Gastroparesis 1Ganglion Cysts 1Esophageal Neoplasms 1Esophageal Motility Disorders 1Esophageal Diseases 1Esophageal Achalasia 1Cluster Headache 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 71apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Botulinum Toxins, Type A × Clear all
NCT01822210 2018-03-09

Botulinum Toxin for Stomach Cancer Treatment

St. Olavs Hospital

Phase 2 Completed
7 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡